Crowdfunding platform Healthfundr will focus on raising investments for life sciences and health care companies with products nearing regulatory approval or that have received approval. "We figure that's where we can add value. Increase the number of innovators that can get past the valley of death," said co-founder Sean Schantzen. Healthfundr staff will work with five to 10 companies at a time and will offer value by reviewing business plans and checking executive backgrounds before soliciting funds with an eye toward getting past the "Series A crunch," Schantzen said.
Published in Brief: